Final-New Material-Rachael Flashcards
Androgens
- androstenedione, DHEA, testrosterone, DHT
- Listed in order of potency
Estrogens and Progestogens
- estrone, estriole, beta-estradiol (“estrogen”)
- Progesterone
Hormone Signaling
- Non-polar hormones: secretion stimulated by stimulating enzymatic reactions
- Hormone bound to proteins in circulation
- Modification by enzymes in target cells
- Testosterone→dihydrotestosterone (DHT), more potent
- Enzyme: 5-alpha-reductase
- Androgens→estrogens
- Enzyme: aromatase
- Testosterone→dihydrotestosterone (DHT), more potent
- Enzymes can be drug targets
- Free hormones diffuses across plasma membrane of target cell
- Signaling via intracellular receptors that act as transcription factors
Hormone Feedback Cycle

Gametes Form by Meiosis
- Germ-cell: gametes and the gamete precursors
- 23 pairs of homologous chromosomes; 22 autosomes; 2 sex chromosomes
- Haploid cell has 23 single chromosomes
- In 1st division, the homologous chromosome pair up.
- Then they divide
- Crossing-over; recombination; variability
- Independent assortment; some of maternal and paternal end up dividing together
- In 2nd division, the chromatids divide up
Nondisjunction lead to aneuploidy
- At first division: 2 of four have n-1, 2 of four have n+1
- At second division: 2 of four are normal, 1 n+1, 1 n-1
Karyotype via amniocentesis or chorionic villus sampling and Cell Free DNA sampling
- Fetal cells: invasive: miscarriage or infection
- Placenta has fetal and maternal cells
- Branching is chorionic plate
- Protrudes into space created in endometrial spaceàmaternal blood flow
- Cell-free fetal DNA analysis:
- Small fragments of DNA enter the maternal circulation
- Early, non-invasive, blood draw
Hormone regulation: pulsatile secretion of GnRH
- GnRH in the hypothalamus
- Anterior pituitary: gonadotropins
- Follicle stimulating hormone (FSH)
- Luteinizing hormone (LH)
- Negative feedback regulation by gonadal steroids
- *Some positive feedback occurs in female
- Gonadotropin (FSH, LH) secretion is stimulated by pulsatile GnRH, inhibited by continuous GnRH
Review of Pituitary Hormones
- 3 hormone chain of command
- Magnocellular vs. parvocellular cell
- Magnocellular release to posterior pituitary
- Parvocellular release to median eminence, delivered directly to anterior pituitary (adenhypophesis)
Continuous Treatment with GnRH
- Continuous treatment with GnRH agonist (eg. Leuprolide) used to turn off reproductive function
- Precocious puberty
- Androgen deprivation therapy for prostate cancer
- Decreased secretion of testosterone
- Used in treatment of prostate cancer, endometriosis, precocious puberty
- Cycle control for IVF
Chronology of reproductive function
- GnRH secretion is high during sexual differentiation, low during childhood, and high after puberty
- Sexual differentiation is before birth
- Gonadal steroid secretion during lifetime in females and males
- Females spike up and down; drops in menopause (estrogen, progesterone)
- Early menopause: look for increase FSH, would occur because of removal of negative feedback inhibition
- Males spike and then slowly decrease with age
- Females spike up and down; drops in menopause (estrogen, progesterone)
Leptin and GnRH
- Leptin is part of a negative feedback loop to control adiposity
- Need leptin to allow GnRH level to increase
- The obese mutant mouse fails to make leptin and suffers from hypogonadotropic hypogonadism
- Leptin is permissive for GnRH secretion
- In abscence, no GnRH, low FSH and LH, decreased gonadal function, infertility
- Doesn’t cause start of period: other factors turning on
- At certain level of leptin, factors more likely to turn on
- Leptin, environmental estrogens
- Hypoleptinemia in women
- Low body fat, low leptin secretion, amenorrhea
Male Reproductive Anatomy
- Sperm develop in seminiferous tubules→epididymis→ductus deferens (vas deferens)→ejaculatory duct→urethra
- Semen: spermatozoa plus seminal fluid
- Seminal fluid made by accessory glands:
- Bulbourethral glands: make least amount of stuff neutralizes traces of urine
- Prostate gland (1)
- Seminal vesicle (2)
Benign Prostatic Hypertrophy (BPH)
- Causes urinary symptoms
- Symptoms in 1/3 men over 50
BPH Drugs
-
Alpha adrenergic antagonists: Tamsulosin (Flomax)
- Relax smooth muscle in urethra
- Really specific for alpha receptors in the urethra and less likely to bind other subtypes-Not have to worry about blood pressure effects as much
-
5-alpha reductase inhibitors
- Dutasteride, finasteride
- Prostate heavily influenced by DHT
- Prevent testosterone to DHT
Prostate Cancer
- Tends to be very slow growing
- Incidence and mortality of prostate cancer: effect of increased screening with PSA test
- Not specific to cancer because BPH also tests positive
- Lots of cancer diagnosis, over diagnosis
- Mortality didn’t actually go down
- Early screening has no benefit on cancer mortality rate
- Best option in most cases is to leave it alone
- Treatment increases morbidity and side effects
- Urinary, defecation, etc. can be messed up
Spermatogenesis
- Differentiation from spermatid to spermatozoon
- Head of sperm:
- Nucleus
- Vesicle called the acrosome
- Contains digestive enzymes
- Important in fertilization
- Sperm made: 100 Million per day, 1000 per second
- Need 15 million sperm per mL for fertility
- Leydig cells: make testosterone

Migration of Developing Sperm in Seminiferous Tubule (Figure)

Sertoli Cells
- Like epithelium that wrap around and hang onto developing germ cells
- Create blood testis barrier
- Between inside of seminiferous tubule and blood
- Tight junx between sertoli cells
- Basal: spermatagonia
- Central: meiosis and mature gametes
- Isolates from immune system (central compartment)
- Nourishing/paracrine signaling required for spermtagonenisis
- Receptors for FSH and testosterone
- Produce androgen binding protein
- Endocrine cells that produce:
- Inhibin: negative feedback
- Mulllerian inhibiting substance (MIS): involved in sexual differentiation
Sertoli Cell Functions: Summary
- Blood testis barrier
- Support gamete development
- Responds to FSH, testosterone
- Synthesize androgen binding protein
- Secrete hormones:
- Inhibin
- Mullerian Inhibiting Substance
Male Hormonal Regulation
- Leydig cells bind to LH
- Sertoli cells bind to FSH
- Negative feedback of tropin
- Not on and off: rather fine tuning
- Muscle mass, bone growth, protein synthesis, secondary sexual structure, sex drive

Physiology of erection
- 1 corpus sponginosum and 2 corpus cavernosa
- Erectile tissues that are vascular spaces that can fill up with blood and become engorged
- Relaxation of arterials and smooth muscles allows blood to flow in
- Maintenance helped because filling up compresses the veins
- neural inputs to arterial smooth muscle of the penis:
- NANC (nonadrenergic, noncholinergic) neurons:
- Releases nitric oxide as neurotransmitter
- Nitrergic neurons
- Sympathetic neurons:
- Release norepinephrine

Erectile Dysfunction Drugs
- Phosphodiesterase inhibitors
- Oral drugs to treat ED
- NO stimulates guanylate cyclase
- Make cGMP
- Lead to decrease in Ca and relaxation
- PDE inactivates pathway by cleaving cGMP
- Sildenafil, vardenafil, tadalafil, avanafil

Ejaculation
- Semen from urethra
- Smooth muscle contraction around the ducts
- Depends on the sympathetic input to smooth muscle
- Vas deferens + Ejaculatory Duct
- Glands
- Internal urethral sphincter
- Release of semen from penis
- Contraction of smooth muscle in urethra
- Contraction of skeletal muscles in pelvic floor
Sexually Indifferent Stage
- During embryonic development
- Adjacent to each primitive gonad
- Wolffian (mesonephric) ducts are more medial
- Müllerian (paramesonephric) ducts are more lateral, but then fuse in the midline more caudally

Sexual Determination: Male
- Sexual determination: depends upon the sex chromosomes, X and Y
- SRY gene on Y chromosome
- activates a gene network that directs the gonads to develop as testes
- No SRY, goes to ovaries
- Testes generate regulatory molecules
- MIS=Mullerian Inhibiting Substance
- peptide hormone

Sexual Determination: Female
- Female in absence of SRY gene

MIS Information
- produced in the ovary (after it differentiates) by granulosa cells
- expressed mainly by small growing follicles
- level of MIS is thus a good indicator of the size of the ovarian reserve
- Used in IVF to predict how the woman will respond to controlled ovarian stimulation
Androgen Insensitivity Syndrome
- Mutation in androgen receptor
- “complete androgen insensitivity”
- Testes develop
- Externally as a female
- development of the male external genitalia depends upon androgen
- Breasts develop because testosterone converted to estrogen
- Recognized via amenorrhea
- Uterus never developed because MIS caused regression
- No armpit or pubic hair because these depend on androgen signaling

Treatment for Androgen Insensitivity Syndrome
- Removal of abdominal testes
- gonadectomy
- Increased risk for testicular cancer
- Cryptorchidism (failure of testes to descend)
- Low androgen levels
- Wait until early adulthood and then gonadectomy so that naturally goes through puberty
- After gonadectomy, kept on hormone therapy
Mutation in 5-alpha-reductase
- Penis and prostate development depends upon dihydrotestosterone (DHT)
- Mutation in 5-alpha-reductase type 2
- Born externally female
- Hypospadias
- Urethra not in phallus but in the perineum
- At pubery the large levles of testosterone stimulate the development of male structures
- Male secondary structures develop
- Initially raised as girls and then develop male gender identity
*

Other Ovarin Development Signals
- Occurs in absence of SRY gene
- But doesn’t occur by default
- Several genes (RSPO1, WNT4, FOXL2) have been shown to be necessary to initiate ovarian development
- actively repress gene network for testes development
Comparing Male vs. Female:
- Spermatagonia
- Spermatocyte divisions
- # of germ cells

Female Oogensis Flowchart

Oocytes develop into follicles
- Prior to birth, oogonia stop proliferating
- At birth, germ cells in ovaries are primary oocytes
- Initiated meiosis but are then in meiotic arrest
- Oocyte+support cells=follicle
- Not developing=primordial follicles
- oocyte in meiotic arrest surrounded by a single layer of follicle cells
- Once starts to develop:
- Oocyte enlarges
- Follicle cells differentiate to granulosa cells, proliferate
- Zona pellucida: glycoproteins
- Spindle shaped theca cells
- Fluid-filled antrum
Follicle Development: Independent Development
- Local signals in ovary cause follicles to develop into early antral stage
- Independent of gonadotropins
- Before puberty and any time in monthly cycle
Follicle Development: Growth Phase
- Follicles that have undergone initial development
- Further stimulated by rising gonadotropins (FSH) and (LH)
- If intial development not later hormonally supported, undergoes atresia
- 99.9%
- Happens all throughout childhood
- Fewer ovulations, less ovarian cancer risk
- Growing, antral follicles
Follicle Development: Dominant Follicle
- Dominant follicle selected by day 7
- Day 7-14 matures
- Egg and small cluster of granulosa cells detaches from wall and follicle floats free within antrum
- Ovulation on day 14
- Follicular phase
Follicle Development: Post Ovulation
- Remaining follicle cells into corpus luteum
- Granulosa cells increase, BM broken down, invaded by blood vessels
- Corpus luteum secretes progesterone and estrogen
- Degenerates day 25 and 28 when LH levels decline
- Fertilized embryo will make chorionic gonadotropin, LH analog that allows corpus luteum to persist during first trimester
- Luteal Phase
Hormonal Regulation: Early Follicular Phase
- Growth stimulated by Gn
- Decreasing estrogen and progesterone from end of cycle release the negative feedback on the anterior pituitary
- FSH=granulosa cells
- LH=theca cells
- Start secreting estrogen
- Granulosa: enzyme aromatase (makes beta estradiol)
- Theca: androgen precurosor

Hormonal Regulation: Selection of Dominant Follicle and Late Follicular Phase
- Follicle enlarges and increases estrogen secretion
- Causes negative feedback inhibition
- Gn levels decline (esp. FSH)
- Granulosa secrete inhibin to prevent FSH
- Selection because negative feedback limits FSH
- Granulosa cells develop LH receptors in late follicular phase and start reponding to LH

Hormonal Regulation: LH surge and Ovulation
- Estrogen from follicle cross threshold and estrogen causes postive feedback
- Causes rapid rise in LH (“surge”)
- Causes ovulation
- Just prior to ovulation, LH causes a blip of progesterone secretion (needed for ovulation)
- First division of meisosis occurs just prior to ovulation

Hormonal Regulation: Luteal Phase
- LH stimulates formation of corpus luteum
- Secretes estrogen and progesterone
- Negative feedback on Gn
- Prevents further follicle development and ovulation
- LH levels fall below a threshold and corpus luteum regresses
- Release hypothalamus and pituitary from negative feedback inhibition
- FSH and LH steadliy increase to start new cycle

Complete Diagram of Female Cycle

Coordination of Uterine Events
- Endometrium into functional layer under estrogen and progesterone control
- Basal layer that regenerates functional layer after menustration
- Middle and Late Follicular Phase:
- High estrogen cause proliferation (proliferative phase); cervix secrete thin watery mucus
- Inductiov of progesterone receptors
- Luteal Phase
- Progestrone prevent further proliferation
- Blood vessel growth
- Secretory Phase
- Cervix secrete thick mucus
- Inhibit contractions
- Menustration
- Drop in progestrone and estrogen
- Vasocontriction causes ischemia
- Later vasodialation to causes bleeding and contraction of myometrium
Menorrhagiae
Dysmenorrhea
- Menorrhagiae: excessive uterine bleeding
- Dysmenorrhea: painful menustration
Leiomyoma
- “Fibroids”
- Benign growths in myometrium
- Abnormal entometrial growth over fibroids leads to excessive bleeding
- More common in older women, have hystorectomy
Unopposed Estrogen
- Occurs in PCOS
- PCOS: annovulation: no switch to luetal or secretory phase
- Lots of estrogen and not a lot of progesterone
- Endometrium keeps proliferating
- Miss a bunch of periods and then have a really bad period
- Increased risk for endometrial cancer
- Treated with hormonal contraceptives
Hyperprolactinemia: Prolactin regulation
- Stimulates milk production in the breast/growth
- Estrogen and progesterone prevent lactation
- Suckling stimulates mechanoreceptors
- Magnocellular Cell:
- Release oxytocin from posterior pituitary
- Milk ejections from myoepithelial cells
- Parvocellular cell that release dopamine at the median eminence
- Dopamine travel to the anterior pituitary via hypophyseal portal vessels and inhibit prolactin secretion
- Suckling inhibits dopamine release

Hyperprolactinemia: Causes and Treatments
- Pituitary tumor (prolactinoma) that secretes prolactin
- Cause infertility because prolactin inhibits GnRH secretion
- Low GnRH, low FSH and LH
- Hypogonadotropic hypogonadism
- anovulation
- amenorrhea and galactorrhea
- osteoprosis
- Dopamine antagonists can cause hyperprolactima
- Gonadal hormone treatment
- First line treatment is dopamine agonist
- bromocriptine and cabergoline

PCOS: Description
- Most common cause of anovulatory infertility
- Chronic ovulation problems with hyperandrogenism
- Amenorrhea or oligomenorrhea
- Hirsutism, acne, hair loss on scalp
- Ovaries enlarged with multiple immature follicels
- Hyperplasia of theca cells
- Fewer granulosa cells
- No domininant follicle chosen and on LH surge
- Often insulin resistant: hyperinsulinemia , greater T2DM risk
- Ultrasound show “necklace of black pearls”
Endocrine disturbances in PCOS
- Normal follicle development when estrogen and progesterone levels drop due to degeneration of corpus luteum
- Granulosa respond to FSH and Theca to LH
- In PCOS, LH secretion is elevated (FSH the same or decreased)
- Theca cells and androgens produced but there is not enough FSH to stimulate granulosa cells
- Failure of follicle development to progress
- Androgen converted to estrogens in adipose tissue
- Abnormal feedback regulation
- LH continues to be high compared to FSH
- Hyperinsulinemia contributes because insulin stimulates androgen production

Treatment for PCOS: Hormonal Contraceptives
- Decrease hyperandrogenism and negative effects on uterus
- Estrogen and progestrone restore normal LH levels
- PCOS causes there to be unopposed estrogen because never progress to luteal phase that has progesterone
- Continued proliferation leading to menorrhagia
- Increases risk for endometrial cancer
Treatment for PCOS: Clomiphene
- SERM
- In hypothalmus and anterior pituirtary, acts as estrogen antagonist
- prevents negative feedback effect of estrogen, allows FSH secretion to increase so that follicle development can be stimulated
- Taken at a certain time in cycle to snap out of bad habits
- Potential for mulitple ovulations
- Alters uterine environment making it harder to concieve
- Usually 1st line in those wanting to concieve
Treatment for PCOS: Aromatase inhibitors
- Letrozole and anastrozole efficicay in ovulation induction
- Prevent androgens from converting to estrogens
- Limit estrogen negative feedback on GnRH
- Shorter half-life allowing normal estrogen secretion later in cycle
- Less risk for multiple ovulations
- More estrogen stimulation of endometrial development during proliferative phase
Tratement for PCOS: insulin sensatizers
- Metformin
- Safe and effective in lowering androgen levels
Treatment for PCOS: Gonadotropins
- Exogenous FSH
- Menotropin
- mixture of gonadotropins from menopausal urine
- Urofollitropin
- purified FSH from urine
- Follitropin
- Recombinant FSH
- FSH may lead to multiple ovulations
- Ovarian hyperstimulation syndrome, increased vascular permeability (edema, nausea, abdominal pain)
- Severe: clotting abnormalities, renal failure, respiratory distress
Treatment for PCOS: Ovarian Surgery
- Induce damage to ovarian tissue
- Breaks the cycle of androgen production and abnormal negative feedback
- No risks of hyperstimulation or multiple pregnancy
PCOS Treatments for women who do not want to concieve
- Hormonal Contraceptives
- Weight Loss
- Metformin
PCOS treatments for women who do want to concieve
- Clomiphene
- Weight Loss
- Aromatase Inhibitors
- Metformin
- FSH
- Surgery
Definition of Conception
- Implantation of fertilized embryo
- Measure by increase in chorionic gonadotropin
- Measure ovulation by LH surge
Hormonal Contraceptive: MOA
- Suppress the secretion of gonadotropins (FSH and LH) thorugh negative feedback inhibition
- Inhibit during luteal phase
- Suppress ovulation
- Prevent rise in FSH needed for initiation of follicle development and selection of dominant follicle
- Prevents LH surge needed to trigger ovulation
- In follicular phase, estrogen makes thin water mucus that sperm can traverse
- In luteal phase, progesterone makes thick mucus. Progesterone in HC does this
- Reduce endometrial growth and interfere with implantation
- Side effect: mid-cycle bleeding from abnormal endometrial proliferation

Combination Contraceptives
- Estrogen and progestin
- Placebo causes withdrawl bleed
- Sign not prego, but not essential
- Continuous for women who suffer menorrhagiae or dysmenorrhea
Progesterone Only Contraceptives
- Low Dose Pills
- Not as reliable at preventing ovulation but work by thickening cervical mucus
- Must be taken at the same time everyday
- Good for lactating mothers
- Long-Acting Methods
- Depo-Provera
- Injected every 3 months
- Inhibition of estrogen may cause loss in bone density
Emergency Contraception

- Block or delay ovulation since sperm can be in reproductive tract for days
- Plan B (levonorgesterol in higher dose)
- Negative feedback inhibitior of GnRH
- Only works if taken before LH surge
- Use within 12 hrs, but can be effective for 5 days
- Ella (ulipristal acetate)
- selective progesterone receptor modulator
- Blocks progesterone action in follicle
- Small increase in progesterone caused by LH surge
- Delay ovulation even if begining of LH surge has already occured
- Not effective if taken after the peak of LH surge
- May affect endometrium, but very low doses so maybe not

Hormonal Contraceptives: Risks
- Cardiovascular Risk
- Rare in young women and pregnancy increases these risks even greater
- Promote thrombosis (VTE); pulmonary embolism, MI or stroke
- Clotting due to estrogen
- Newer progestin (drospirenone, desogestrel) have higher risk than older (levonorgestrel)
- Breast Cancer
- Tumors stimulated by estrogen
- Estrogen and Progesteronen promote breast growth
- No increase in breast cancer (but study done in older women)
*
Hormonal Contraceptives: Benefits
- Menstural Symptoms:
- Menorrhagia, dysmenorrhea, PCOS
- Endometrial Cancer:
- Decreased endometrial proliferation
- Lowest risk in those of HC for longest
- Ovarian Cancer:
- Lowest risk in those on HC for longest
- Androgen Secretion
- Treat hyperandrogenism because decrease gonadotropin androgen secretion
- Reduce severity of acne
Mifepristone
- Progesterone antagonist
- Terminate pregnancy in first 7 weeks
- Need progesterone to keep gestation
- Progesterone maintains endometrium and quiet myometrium
- Mifepristone and then prostaglandins
- prostaglandins induce myometrial contractions
- Mifepristone induces shedding of endometrium
- Ella progesterone antagonist is used at a much lower dose
Acrosome Reaction
- Sperm matures as goes through female reproductive tract
- Acrosome: large vesicle in head of sperm; contains digestive enzymes
- Sperm bind to zona pellucida; acrosome reaction is undergone
- Release of digest enzyme; allows sperm to burrow through zona pellucida
- Many sperm undergo acrosome reaction, but only one “wins”
- Once sperm membrane fuses with egg membrane; triggers a reaction in the ovum (cortical reaction)
Cortical Reaction
- Exocytosis of vesicles
- Change the zona pellucida; zona hardening
- Other sperms that are bound fall off and prevents other sperms from fertilizing the egg
- Zona pellucida stay with the fertilized egg (conceptus)
- Give rise to embryo and extra embryonic tissue
- Sperm-egg fusion stimulated the second division of meiosis
- Male and Female pronucleus fuse and then divide to make zygote (other female nucleus is the polar body)
First Cell Divisions in Pregnancy
- First cell divisions through fallopian tube occur without any growth; cleavage
- 70-100 cells
- Zona pellucida prevents it from implanting where it shouldn’t
- Blastocyst
Implantation-stage conceptus: blastocyst
- Once reaches the uterus, there is zona hatching
- Two kinds of cell in blastocyst
- Trophoblast: Outer layer that forms extra embryonic tissue (chorion)
- Inner Cell Mass: Cell concentrated on one side; forms embryo
Trophoblast
- Trophoblast is sticky and adheres to endometrium
- Promotes proliferation
- Divides into two groups
- Syncytial trophoblast: cell membrane break down, so many nuclei in one membrane
- Invasive into endometrium
- Proteolytic enzymes
- Makes chorionic gonadotropin
- Makes lacuna
- Cellular trophoblast: normal cells
- Forms chorionic villi

Implantation
- Occurs 6 to 7 days after fertilization
- syncytial trophoblast
- invasisive and proteolytic enzymes
- embyro nourished by digestion of endometrium
- Digestion of endometrial tissue creates lacunae
- produce chorionic gonadotropin
- Pregnancy test
- LH analog, maintains corpus luteum
- invasisive and proteolytic enzymes
- Cellular trophobasts create branched structures, known as chorionic villi
- developing embryo forms a disc that pulls away from the proliferating trophoblast to create a new space
- amniotic cavity

The Placenta
- from the trophoblast and the endometrium
- during pregnancy the endometrium is known as the decidua
- Placenta 5 wks after implantation
- fetal part of the placenta, or chorion, is made up of the chorionic villi
- branched
- blood vessels just under trophoblast layer
- villi protrude into large spaces (lacunae) in the decidua
- maternal blood into lacunae to wash over villi
- exchange of nutrients, wastes, and blood gases
- maternal blood into lacunae to wash over villi
- Source of estrogen and progesterone after 8 weeks of pregnancy
Development of the Amnion
- Development of the amnion
- Fluid filled
- Chorion develops on one side and then fuses with the amnion
- Chorion will be on one side of the uterus
Estrogen and Progesterone in Pregnancy: Immplantation
- Gonadosteroid make the uterus prime for immplantation
- Estrogen in follicular phase proliferates endometrium
- Progesterone in luteal phase stimulates secretion and promotes blood vessel growth
- Estrogen and Progesterone by corpus luteum
- Early in pregnangy CL stimualted by HCG
- By 4 weeks there are detectable levels of HCG
Estrogen and Progesterone in Pregnancy: Gestation
- Progesterone: smooth muscle relaxation in the myometrium, developmental changes in endometrium for decidua formation
- Progesterone supplementation in women who have a history of preterm labor
Graph of Hormonal Changes in Pregnancy

Estrogen and Progesterone in Pregnancy: Preparation for Lactation
- Progesterone stimulates growth of milk-producing cells in the glands
- Estrogen stimulates growth of duct cells
- Estrogen stimulated prolactin
Partruition
- Delivery of infant and placenta
- Estrogen stimulates proliferation in the myometrium
- synthesis of gap junctions between myometrial smooth muscle cells
- Coordinated contraction
- synthesis of enzymes involved in prostaglandin synthesis
- Prostaglandin cervical ripening
- Soft, flexible and dialated
- Prostaglandins stimualte myometrial contractions
- oxytocin is the strongest stimulator of uterine contractions
- estrogen increases responsiveness to oxytocin by increasing expression of oxytocin receptors
Partruition: Hormonal Loop
- Head pushes head against the cervix
- Stretch receptors in the cervix
- Feed onto the hypothalamus
- Activate neurosecretory cells to release more oxytocin
- Positive feeback stimulation to make sure that the baby is born “all the way”

Strucutre of the Breast
- Milk is produced by secretory structures known as alveoli
- Alveoli are arranged in clusters called lobules
- The lobules are connected to outlets at the nipple by ducts
- The alveoli are surrounded by special contractile cells known as myoepithelial cells.
congenital adrenal hyperplasia
- Problems with sexual differentiation of XX infants
- when excess androgens are produced during development
- can be due to an adrenal tumor in the mother
- most often in the disorder known as congenital adrenal hyperplasia
- defects in the enzymatic pathways that produce cortisol
- Low cortisol cannot exert negative feedback regulation on the secretion of the pituitary hormone ACTH, which stimulates hormone production by the adrenal gland
- adrenal glands produce large amounts of androgens, which have the effect of masculinizing XX females
- precocious sexual development in males
Cryptorchidism
- Failure of both testes to descend into the scrotum by birth
- Surgical correction of cryptorchidism is done ideally before 2 years of age and is known as orchiopexy
- Cryptorchidism increases risk for testicular cancer and orchiopexy reduces this risk
Testicular cancer
- most common malignancy in young men
- vast majority of testicular cancers (95%) are germ cell tumors
- these tumors arise when there is disrupted growth and development of germ cell precursors
- the cure rate approaches 80%
- removal of the tumor, followed by radiation, or chemotherapy
- chemotherapy drug cisplatin has proved to be very effective in the treatment of testicular cancer
Benign Prostatic Hyperplasia
- non-cancerous growth of the prostate gland
- pelvic pain and difficulty in urination
- prostate is more responsive to DHT, one therapeutic approach uses 5-a-reductase inhibitors, such as dutasteride and finasteride
- Another medical approach is to use a–blockers (an example is tamsulosin), which relax smooth muscle in the prostate and urethra to ease urinary symptoms
- Surgical resection of the enlarged prostate can also be done using an instrument inserted in the urethra.
Prostate Cancer
- most frequently diagnosed cancer among men in the United States
- Detection of prostate tumors was traditionally done by digital rectal examination
- Prostate-specific antigen (PSA) is a protein produced by the prostate, and its levels rise in the blood when the prostate enlarges, as it would if a tumor was present
- high rates of false positives and false negatives
- Treat with hormonal therapy
- Radiation
- prostatectomy
Breast Cancer
- mammography also causes overdiagnosis, that is, the identification of tumors that may not be otherwise clinically significant in a woman’s lifetime
- non-invasive (confined to breast ducts or lobules) or invasive (spread to surrounding connective tissue)
- Another term for non-invasive breast cancer is carcinoma in situ
- To determine whether breast cancer has metastasized, the axillary lymph nodes (lymph nodes of the armpit) are dissected and examined.
- over-expresses hormone receptors (either for estrogen or progesterone) or the growth factor receptor HER2
- treat it with drugs that interfere with estrogen, such as tamoxifen (which is a selective estrogen receptor modulator; SERM) or letrozole (an aromatase inhibitor that prevents estrogen synthesis). Tumors that are positive for HER2 are treated with trastuzumab (tradename: Herceptin), an antibody-based drug that binds to the receptor and prevents cell growth.
Breast Cancer Surgery
- mastectomy (removal of the breast) or lumpectomy, in which the tumor and surrounding tissue are removed
- lumpectomy after radiation
- Adjuvant therapy refers to any of the various systemic therapies: chemotherapy, hormone therapy, or trastuzumab.
Breast Cancer and HRT
- hormone replacement therapy increased the risk of heart disease and breast cancer
PID
- acute infection of the upper reproductive tract in women, namely endometritis
- salpingitis (infection of the fallopian tubes)
- oophoritis (infection of the ovaries)
- Usually by the clap
- pelvic pain, tenderness upon palpation, and (sometimes, but not always) vaginal discharge
- Can lead to infertility and tubal dysfunction
- Treat with antibiotics
Endometriosis
- endometrial tissue is found in ectopic locations, usually in the pelvic cavity
- pelvic pain, tissue damage, and lowered fertility
- retrograde menstruation (i.e. menstruation through the fallopian tube instead of the cervix) allows ectopic endometrial tissue to implant in the pelvic cavity
- persist there due to an insufficient immune response
- treated surgically, or with drugs that decrease estrogen levels such as oral contraceptives or the GnRH agonist leuprolide
Dysmenorrhea
- painful menstruation
- High prostaglandin levels
- sensitize pain fibers in the uterus
- treated effectively with NSAIDs (non-steroidal anti-inflammatory drugs)
- oral contraceptives
- Progesterone opposes prostaglandin function
- less endometrium overal lowers prostaglandin secretion as well
Menopause
- end of ovarian follicle production, there is also a marked drop in production of estrogen
- decrease in the size of the breasts and uterus
- bone density and cardiovascular system
- lack of estrogen leading to hot flash
- HRT for vaginal dryness and hot flash and osteoporosis
- Treatment of estrogen loss:
- selective estrogen receptor modulators (SERMs), such as raloxifen
- act as estrogen antagonists in some tissues, while acting as estrogen agonists in other tissues
- Raloxifene may now also be prescribed to prevent breast cancer in post-menopausal women at high risk for invasive breast cancer.